Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2010.05.19
第一届董事会第十八次会议决议公告
2010.05.19
关于签订《募集资金三方监管协议》的公告
2010.05.15
澄清公告
2010.05.13
股票交易异常波动公告
2010.05.05
2010年第一季度财务资料
2010.05.05
首次公开发行股票上市公告书
2010.05.05
北京市中伦律师事务所关于公司首次公开发行的股票申请在深圳证券交易所上市的法律意见...
2010.05.05
中国建银投资证券有限责任公司关于公司股票上市保荐书
2010.04.29
首次公开发行股票网上定价发行摇号中签结果公告
2010.04.28
首次公开发行股票网下配售结果公告
第一页
上一页
152
153
154
155
156
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
